CLINICAL_TRIALS
trial_result
· 2025-02-05
Clinical Trial Update: A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS) [Phase 1]
Summary
A Phase 1 study of TAK-951 in participants with cyclic vomiting syndrome was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Nausea and Vomitting | Phase 1 | Status: TERMINATED | Results posted: 2025-02-05